Ranbaxy Laboratories Ltd has announced that a meeting of the Board of Directors of the Company will be held on October 19, 2006, inter alia, to consider following:
1. Unaudited Financial Results (Provisional) for the third quarter ended September 30, 2006 (Q3).
2. Interim Dividend on Equity Shares for the year ending December 31, 2006.
